Heron Therapeutics, Inc. (NASDAQ: HRTX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT HERON THERAPEUTICS, INC.

Heron Therapeutics, Inc. (NASDAQ: HRTX)
Listen to this Section


$0.44
-0.0405 ( -8.38% ) 2.7M

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Market Data


Open $0.44
Previous Close $0.48
Volume 2.7M
Market Cap $84.57M
Day Range $0.44 - $0.49
52 Week Range $0.43 - $2.30
Shares Outstanding 189.28M
Change % -8.38%
Net Change ▼ -0.0405
Insider Ownership -0.01%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year1987
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 2,110,114.00

Date Type Amount Purchased Purchaser
2025-08-12 Buy 2387225.00 Rubric Capital Management LP
2025-08-12 Buy 1766546.00 Morgan Adam
2024-07-22 Sale -13797.00 Collard Craig A
2024-07-22 Sale -3875.00 Forbes William P
2024-07-22 Sale -3875.00 Duarte Ira
2024-06-17 Sale -12500.00 Duarte Ira
2024-06-07 Sale -12500.00 Forbes William P
2024-04-19 Sale -3874.00 Duarte Ira
2024-04-19 Sale -3874.00 Forbes William P
2024-04-19 Sale -13797.00 Collard Craig A

SEC Filings


Form Type Description Pages Date
8-k 8K-related 10 Aug 12, 2025
8-k 8K-related 12 Aug 08, 2025
10-q Quarterly Reports 61 Aug 08, 2025
4 Insider transactions 1 Aug 04, 2025
4 Insider transactions 1 Aug 04, 2025
4 Insider transactions 1 Aug 04, 2025
4 Insider transactions 1 Jul 22, 2025
4 Insider transactions 1 Jul 22, 2025
4 Insider transactions 1 Jul 22, 2025
8-k 8K-related 11 Jun 18, 2025

Latest News


× Before browsing our site, please accept our cookies policy